Events archive
11.
2022
IOR Lecture Series - "Nutrient dependencies of metastasis formation"
Institute of Oncology Research
10.
2022
IOR Lecture Series - Inflammatory Signaling in Prostate Cancer Progression
Institute of Oncology Research
07.
2022
IOR Lecture Series - Toward AI-Driven Precision Medicine
Institute of Oncology Research
06.
2022
IOR Lecture Series - Moving forward precision medicine in patients with cancer
Institute of Oncology Research
06.
2022
IOR Lecture Series - Dietary Control of Prostate Cancer
Institute of Oncology Research
05.
2022
Porte aperte degli Istituti di Ricerca di Bellinzona (Bios+)
Institute of Oncology Research
05.
2022
IOR Lecture Series - Insights gained from investigating genomic junk
Institute of Oncology Research
IOR Lecture Series - International PhD Program in Cancer Biology and Oncology
Institute of Oncology Research
04.
2022
Translational Prostate Cancer Symposium: Horizons in Prostate Cancer Research
Institute of Oncology Research
04.
2022
IOR Lecture Series - Lineage Plasticity and the Neuroendocrine Phenotype in Prostate Cancer
Institute of Oncology Research
03.
2022
Preclinical Development of Cancer Nanomedicines: State of the Art and Future Perspectives
Institute of Oncology Research
03.
2022
IOR Lecture Series - Genomics of Diffuse Large B Cell Lymphoma: Pervasive role of mutations in super-enhancers
Institute of Oncology Research
03.
2022
Castelgrande Lecture - La nuova medicina di precisione in oncologia: l'esempio del linfoma
Institute of Oncology Research
02.
2022
IOR Lecture Series - International PhD Program in Cancer Biology and Oncology
Institute of Oncology Research
01.
2022
IOR Lecture Series - New insights into old tumor suppressors
Institute of Oncology Research
12.
2021
IOR Lecture Series - Cancer Epigenomics and Epitranscriptomics: From Knowledge to Applications
Institute of Oncology Research
11.
2021
Bellinzona Institutes of science: new building inauguration - LIVE STREAMING
Institute of Oncology Research
09.
2021
IOR Lecture Series - Circulating markers in the plasma of CRPC patients: challenges and opportunities
Institute of Oncology Research